Helen S. Kim is a Senior Managing Director at Vida Ventures, LLC where she invests in biotechnology and biopharmaceuticals across life sciences sectors including oncology, gene therapy, neuroscience, and immunology, with activity in the United States and Europe from seed through post-IPO stages. She serves on the boards of Prothena Corporation plc, InduPro, Aktis Oncology, IconOVir Bio, and ReCode Therapeutics, and has invested in companies like A2 Biotherapeutics, Protego Biopharma, ReCode Therapeutics, IconOVir Bio, and Aktis Oncology. Previously, she held executive management positions at NGM Biopharmaceuticals, Kosan, Affymax, Onyx, Protein Design Labs, and Chiron, and served on the boards of Applied Molecular Transport and Assembly Biosciences. Helen holds a BS in Chemical Engineering from Northwestern University and an MBA from the University of Chicago Booth School of Business, and resides in Santa Monica, California, United States.
Helen S. Kim, Senior Managing Director @ Vida. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Helen S. Kim from Prothena Corporation plc. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Helen
Map your path to Helen instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Helen
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.